Table 1.
Age-dependent increase of mtDNA heteroplasmy incidence in lymphoblast samples
| Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
| mtDNA heteroplasmy | Beta [95% CI] | P | Beta [95% CI] | P | Beta [95% CI] | P | 
| VAF ≥ 1% | 0.012 [0.005–0.020] | 0.00063 | 0.012 [0.005–0.019] | 0.00073 | 0.014 [0.005–0.022] | 0.0012 | 
| VAF ≥ 2% | 0.017 [0.007–0.027] | 0.00087 | 0.017 [0.007–0.026] | 0.00091 | 0.020 [0.009–0.031] | 0.00043 | 
| VAF ≥ 5% | 0.027 [0.013–0.042] | 0.00025 | 0.027 [0.013–0.042] | 0.00026 | 0.037 [0.020–0.054] | 2.7 × 10−5 | 
The associations between heteroplasmy incidence and age were computed by using Poisson log-linear model with adjustment for sex and sequencing coverage in model 1, and for sex, sequencing coverage, and the relative mtDNA content (STAMP-CN) in model 2 and model 3. In model 3, only heteroplasmies that occurred once in the 182 lymphoblast samples were used to compute the incidence.